PLUREXA Trademark

Trademark Overview


On Saturday, November 26, 2022, a trademark application was filed for PLUREXA with the United States Patent and Trademark Office. The USPTO has given the PLUREXA trademark a serial number of 97692503. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2024. This trademark is owned by Plurexa LLC. The PLUREXA trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for research or scientific purposes; Stem cells for research purposes

Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Research in the field of cell engineering technology; Research in the field of gene editing technology; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biomedical research services; Biotechnology research; Cell culture services for scientific and research purposes, for others; Chemical research; Chemical research and analysis; Chemical research services; Consulting services in the field of pharmaceutical research and development; Culturing of cells for others for scientific research purposes; Genetic testing for scientific research purposes; Pharmaceutical researc...
plurexa

General Information


Serial Number97692503
Word MarkPLUREXA
Filing DateSaturday, November 26, 2022
Status700 - REGISTERED
Status DateTuesday, September 17, 2024
Registration Number7509068
Registration DateTuesday, September 17, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Goods and ServicesCells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for research or scientific purposes; Stem cells for research purposes
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Research in the field of cell engineering technology; Research in the field of gene editing technology; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biomedical research services; Biotechnology research; Cell culture services for scientific and research purposes, for others; Chemical research; Chemical research and analysis; Chemical research services; Consulting services in the field of pharmaceutical research and development; Culturing of cells for others for scientific research purposes; Genetic testing for scientific research purposes; Pharmaceutical research and development; Pharmaceutical research services; Physics research; Product research; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research; Scientific research and development; Scientific research consulting; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, December 19, 2022
Primary Code001
First Use Anywhere DateWednesday, April 12, 2023
First Use In Commerce DateWednesday, April 12, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 19, 2022
Primary Code042
First Use Anywhere DateWednesday, April 12, 2023
First Use In Commerce DateWednesday, April 12, 2023

Trademark Owner History


Party NamePlurexa LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSeattle, WA 98109

Party NamePlurexa LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSeattle, WA 98109

Party NamePlurexa LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Wednesday, November 30, 2022NEW APPLICATION ENTERED
Monday, December 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 6, 2023ASSIGNED TO EXAMINER
Wednesday, September 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 4, 2024USE AMENDMENT FILED
Saturday, May 4, 2024TEAS STATEMENT OF USE RECEIVED
Friday, June 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 9, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 17, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, June 8, 2024STATEMENT OF USE PROCESSING COMPLETE